PressNovember 14, 2022 Psychedelic-Assisted Therapy Company Better U Creates Military Liaison Officer Position to Help Expand Access to Veterans
PressNovember 14, 2022 TRIPSITTER CLINIC LTD. ANNOUNCES THE CLOSING OF ASSETS ACQUISITION DEAL WITH RECONCIOUS MEDICAL AND APPOINTMENT OF DR. MARK BRAUNSTEIN AS CHAIRMAN
PressNovember 11, 2022 Silo Pharma Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation
PressNovember 11, 2022 Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
PressNovember 10, 2022 Filament Health Announces Third Quarter 2022 Financial Results and Operational Highlights
PressNovember 10, 2022 GoodCap Pharmaceuticals and the University of Toronto Awarded NSERC Alliance Grant for Ongoing Research of Low-Dose Psilocybin Drug Formulas Targeting Inflammation and Depressive Disorders
PressNovember 10, 2022 Tryp Therapeutics Announces Poster Presentations on the Reduction of Chronic Pain in a Rodent Model with Psilocybin and Intravenous Psilocybin Alters Brain Network Dynamics in Rats at the 2022 Society for Neuroscience Conference
PressNovember 10, 2022 Awakn Life Sciences Signs Its Third Licensing Partnership Agreement in North America, and First in New York
PressNovember 10, 2022 Irwin Naturals Looks to Add Pacific Northwest Ketamine Clinic to Its National Footprint
PressNovember 9, 2022 Beckley Psytech Announces First Participant Dosed in Phase I Trial of ELE-101, A Novel Intravenous Formulation of Psilocin
PressNovember 9, 2022 Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial, CEO Clips Video
PressNovember 7, 2022 Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET
PressNovember 7, 2022 Revitalist CEO Awarded Professional Service Practitioner of the Year by Microdose
PressNovember 4, 2022 Biomind Labs Announces Positive Initial Results From Its Phase II Trial on Its BMND01 Candidate for Treatment Resistant Depression
